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1. Introduction 
The problem of a possible precursor-product rela- 
tionship between the major brain gangliosides has 
earlier been studied in vivo by Suzuki and Korey [1 ], 
Maccioni and colleagues [2] and ourselves [3]. La- 
belled acetate and glucosamine were injected intrace- 
rebrally and the specific activities of sialidase labile 
and stable sialic acid of the individual gangliosides 
were determined atdifferent intervals after precursor 
injection. To obtain more accurate data on the in vivo 
relationship, an immediate precursor of sialic acid, 
N-acetylmannosamine [4, 5], was injected intracere. 
brally in young rats. The sialidase labile and stable 
acids from the gangliosides GM1, GDla, GD1 b and 
GT1 (nomenclature of L. Svennerholm, [6]) were iso- 
lated by Sephadex G-25 column chromatography. The 
specific activity of sialidase stable sialic acid was low- 
er than that of sialidase labile sialic acid. No signifi- 
cant differences between the activities of the sialic 
acid from different gangliosides were obtained. 
2. Experimental 
2.1. Materials, precursor injection and ganglioside iso- 
lation 
N- [Acety1-3 H] mannosamine (75/aCi), 500 mCi/ 
rrmaole (Radiochemical Centre, Amersham, England), 
in 100 tzl of sterile isotone saline, was injected intra- 
cerebrally in each of 48 8-day-old rats of the Sprague- 
Dawley strain. The animals were killed 1.5, 3, 6 and 
12 hr after the injection in groups of 12 rats, and the 
cerebra were taken out, pooled and stored at -20°C 
until lipid extraction. The gangliosides were extracted 
by chloroform-methanol (1: 1, v/v), and separated 
from the predominant portion of other lipids by col- 
umn chromatography on Silica Gel H (Fluka AG, 
Buchs, Switzerland) [3]. The crude ganglioside frac- 
tion was further purified by alkaline hydrolysis. The 
hydrolysate was neutralized with HC1 and desalted on 
a Sephadex G-25 column (Pharmacia Fine Chemicals, 
Uppsala, Sweden) [7]. The major gangliosides, GM1, 
GD1 a, GD1 b and GT1 were isolated by preparative 
thin-layer chromatography [3 ]. 
2.2. Isolation of  sialidase labile sialic acid 
Thirty nmoles of each ganglioside was evaporated 
in a small Kimax tube. Fifty/al of water, 5/al of 1 M 
Tris-maleate buffer, pH 7.3, and 5/al of sialidase, 
500 units/ml (Behringwerke, Marburg/Lahn) were 
added. The mixture was incubated for 16 hr at 37°C. 
The incubate was evaporated todryness and dissolved 
in 5 ml of chloroform-methanol-water (60:30:4.5, 
by vol) and applied to a 1 g Sephadex G-25 column. 
The gangliosides stable to the sialidase treatment were 
eluted by 5 ml of chloroform-methanol-water 
(60:30:4.5, by vol) and 5 ml of chloroform-metha- 
nol (2: 1, v/v). The liberated sialic acid was eluted 
from the column by 8 ml of methanol-water (1:1, 
v/v). 
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2.3. Isolation of  sialidase stable sialic acid 
The sialidase treated gangliosides were hydrolysed 
in 1 ml of 1 M formic acid in a Kimax tube for 1 hr 
in a boiling water bath. After evaporation the liber- 
ated sialic acid was isolated on a 1 g Sephadex G-25 
column as described above. 
2.4. Radioactivity determination 
The samples of sialic acid were evaporated and dis- 
solved in 2 ml of water. The amount of sialic acid was 
determined by the resorcinol method [8] on dupli- 
cate samples of 0.5 ml each. For radioactivity deter- 
mination 0.8 ml of the sialic acid solution was added 
to 10 ml of Instagel (Packard). Scintillation counting 
was performed for 10 min in a Packard Tri-Carb Scin- 
tillation Spectrophotometer, with a 50-1000 window 
and 48% gain. Quenching was checked by a channel 
ratio method. 
2.5. Statistics 
The S.D. of the specific activity as percentage of 
the mean was determined by duplicate analysis of 
sialidase labile and stable sialic acid from GD1 a and 
GT1 6 and 12 hr after precursor injection [9]. 
3. Results 
3.1. The S.D. obtained for the specific activity of 
sialic acids from GD1 a and GT1 6 and 12 hr after pre- 
cursor injection was 7% of the mean. The yield of 
sialic acid obtained by sialidase treatment was in all 
cases more than 95% of the theoretical value. 
3.2. The specific activities of the sialidase labile and 
stable sialic acid are given in fig. 1. The specific activ- 
ities for sialidase sialic acid of GDla, GD1 b and GT1 
were lower than the specific activities of correspond- 
ing sialidase labile sialic acid. The specific activities of 
the sialidase labile sialic acids were linear up to 6 hr 
after precursor injection. The activity curves for 
sialidase stable sialic acid were lower in GD1 b and 
GT1 than in GD1 a and GM1. 
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Fig. 1. Specific activities of sialidase labile (o) and stable (A) 
sialic acid in cerebral GMI , GDla, GD1 b and 3C~.1 after an 
intracerebral injection of 75 uCi of N-[acetyl- H] -mannos- 
amine into 8-day-old rats. Duplicate analysis for 6 and 12 hr 
GM1, GD1 a and GT1 ; otherwise single analysis. 
4. Discussion 
4.1. The specific activities of the sialidase stable sialic 
acid were lower, in all cases, than those of the labile 
sialic acid. These results confirm those obtained pre- 
viously by us [3] but they are in contradiction to 
those of Suzuki and Korey [1] and Maccioni et al. 
[2]. The reliability of our results has, however, been 
increased by the fact that the standard eviation of 
the specific activity determinations was only 7%. The 
most probable xplanation to our results is that there 
is a small fraction of previously synthetised GM1 with 
unlabelled sialic acid, which will serve as precursor 
for the formation of di- and tri sialoganglioside. An- 
other possibility is that the stable sialic acid is incor- 
porated into the ganliosides from a sialic acid pool 
different from the pool which furnishes the labile 
sialic acid. 
4.2. The increase of the specific activities of the siali- 
dase labile sialic acids was linear up to 6 hr after the 
precursor injection. Thus the specific activity of the 
precursor sialic acid pool was constant during these 
6 hr, presuming "asteady biosynthetic rate. This could 
only occur by a feed-back inhibition of the synthesis 
of sialic acid. Such a mechanism has in fact already 
been suggested by Kornfeld and co-workers [10]. 
They proposed that CMP-N-acetylneuraminic acid, 
272 
Volume 38, number 3 FEBS LETTERS January 1974 
activated sialic acid, acted as an inhibitor for the for- 
mation of N-acetylmannosamine from N-acetylglucos- 
amine. The injected N-acetylmannosamine  our ex- 
periment may initially have given such a large pool of  
sialic acid that the biosynthesis of  N-acetylmannos- 
amine was temporarily inhibited. 
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